Viewing Study NCT00648102


Ignite Creation Date: 2025-12-25 @ 3:57 AM
Ignite Modification Date: 2026-02-23 @ 3:18 PM
Study NCT ID: NCT00648102
Status: COMPLETED
Last Update Posted: 2010-07-26
First Post: 2008-03-28
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: Phase I Study of CDX-1307, hCG-B Vaccine, for Patients With Incurable, Locally Advanced or Metastatic Breast, Colorectal, Pancreatic, Bladder or Ovarian Cancer
Sponsor: Celldex Therapeutics
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module